Eva Vilarrasa Rull

5PUBLICATIONS
26CO-AUTHORS
Disease surveillanceDermatologyPredictive and prognostic markersAllergyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 31, 2026
Effectiveness and Safety of 40 mg Modified-Release Doxycycline for the Treatment of Hidradenitis Suppurativa: A Single-Center Retrospective Observational Study.

|Jun 23, 2026
Modalities of Combined Medical and Surgical Treatment in Hidradenitis Suppurativa: A Systematic Review of Efficacy and Safety.

|Sep 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review.

Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull

|Aug 27, 2025
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.

Miguel Mansilla-Polo, Carmen García-Moronta, Pablo Fernández-Crehuet

|Aug 10, 2023
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.

Nerea Manzanares, Eva Vilarrasa, Anna López

Pageof 1

Frequent Collaborators

2 joint publications

Alejandro Molina-Leyva

1 joint publications

Nerea Manzanares

1 joint publications

Anna López

1 joint publications

Josep Riera